Scientists have identified a simple blood test that measures insulin resistance which may also help doctors determine which ...

SOUTH SAN FRANCISCO, Calif., June 27, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that ...

Phase 3 study met primary and most key secondary clinical endpoints This marks the third developmental and epileptic encephalopathies (DEE) population for fenfluramine ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ('Clearmind” or the 'Company'), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...

First-in-human trial of AX-0810 will evaluate safety, tolerability, pharmacokinetics, and target engagement in healthy volunteers with initial data expected in Q4 2025Marks the first submitted Clinica ...

Manchester’s inward investment agency MIDAS has launched a new life sciences prospectus showcasing the city-region's strength in the sector. Business leaders also hailed ...

There were sleepless nights, buckets of tears, and an aching pit in my stomach. Getting a cancer diagnosis is terrifying. It ...

Two UBC Southern Medical Program (SMP) graduates are helping change how cancer survivors receive follow-up care in rural BC, ...

Dr. Brad Nelson has been named B.C. Cancer Victoria’s Lynda and Murray Farmer Immunotherapy Research Chair, which means he ...

Learn how insights and continuous therapy are transforming chronic lymphocytic leukemia care, empowering patients to live ...

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with ...